Related Articles
Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells
Overexpression of xeroderma pigmentosum group C decreases the chemotherapeutic sensitivity of colorectal carcinoma cells to cisplatin
TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma
RRM2‑mediated Wnt/β‑catenin signaling pathway activation in lung adenocarcinoma: A potential prognostic biomarker
AFAP1‑AS1 induces cisplatin resistance in non‑small cell lung cancer through PI3K/AKT pathway